ZILXI: payments to doctors
Payments that named ZILXI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $792K
- Providers
- 3,549
- Transactions
- 10,884
- Average per transaction
- $73
The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,549 providers the average total is $223, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| VYNE Pharmaceuticals Inc. | $792,367 | 100.0% |